Vindesine |
|
| Compound 112531; Desacetylvinblastine Amide; EG Labo Brand of Vindesine Sulfate; Eldisine; Enison; Lilly Brand of Vindesine Sulfate; NSC-245467; Vindesin; Vindesine Sulfate; NSC 245467; NSC245467; Sulfate, Vindesine | |
| Vinblastine derivative with antineoplastic activity against acute leukemia, lung cancer, carcinoma of the breast, squamous cell carcinoma of the esophagus, head, and neck, and Hodgkin's and non-Hodgkin's lymphomas. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols. | |